CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickey, R.
Right arrow Articles by Masters, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickey, R.
Right arrow Articles by Masters, R. W.

Canadian Journal of Anesthesia, Vol 37, 732-738, Copyright © 1990 by Canadian Anesthesiologists' Society


ARTICLES

Brachial plexus block with a new local anaesthetic: 0.5 per cent ropivacaine

R Hickey, KD Candido, S Ramamurthy, AP Winnie, J Blanchard, SM Raza, J Hoffman, Z Durrani and RW Masters
Department of Anesthesiology, University of Texas, Health Science Center, San Antonio 78284.

A new local anaesthetic, ropivacaine hydrochloride, was used in a concentration of 0.5 per cent in 32 patients receiving a subclavian perivascular block for upper extremity surgery. One group (n = 15) received 0.5 per cent ropivacaine without epinephrine and a second group (n = 17) received 0.5 per cent ropivacaine with epinephrine in a concentration of 1:200,000. Anaesthesia was achieved in 87 per cent of the patients in both groups in all of the C5 through T1 brachial plexus dermatomes. Motor block was profound with 100 per cent of patients in both groups developing paresis at both the shoulder and hand and 100 per cent developing paralysis at the shoulder. There was a rapid initial onset of sensory block (a mean of less than four minutes for analgesia) with a prolonged duration (a mean of greater than 13 hr of analgesia). The addition of epinephrine did not significantly affect the quality or onset of sensory or motor block. The duration of sensory block was reduced by epinephrine at T1 for analgesia and at C7, C8, and T1 for anaesthesia. The duration of sensory block in the remaining brachial plexus dermatomes as well as the duration of motor block was not effected by epinephrine. There was no evidence of cardiovascular or central nervous system toxicity in either group with a mean dose of 2.5-2.6 mg.kg-1 ropivacaine.


This article has been cited by other articles:


Home page
Anesth. Analg.Home page
A. Weber, R. Fournier, E. Van Gessel, N. Riand, and Z. Gamulin
Epinephrine Does Not Prolong the Analgesia of 20 mL Ropivacaine 0.5% or 0.2% in a Femoral Three-In-One Block
Anesth. Analg., November 1, 2001; 93(5): 1327 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J. B. Whiteside and J. A. W. Wildsmith
Developments in local anaesthetic drugs
Br. J. Anaesth., July 1, 2001; 87(1): 27 - 35.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. R. M. Janzen, A. J. Vipond, D. J. Bush, and P. M. Hopkins
A Comparison of 1% Prilocaine with 0.5% Ropivacaine for Outpatient-Based Surgery Under Axillary Brachial Plexus Block
Anesth. Analg., July 1, 2001; 93(1): 187 - 191.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
C. Connolly, D. M. Coventry, and J. A. W. Wildsmith
Double-blind comparison of ropivacaine 7.5 mg ml-1 with bupivacaine 5 mg ml-1 for sciatic nerve block
Br. J. Anaesth., May 1, 2001; 86(5): 674 - 677.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Canadian Anesthesiologists' Society.